dish
Company


We are transforming immunotherapy discovery and development using our proprietary platform to extensively interrogate cells of the human immune system for candidate selection and validation. We are building a pipeline of antibody product candidates for the treatment of cancer and inflammatory diseases. Our unique capabilities enable us to measure drug effects in a patient-specific manner, providing the basis for developing best-in-class product candidates, based on a fundamental understanding of how immunotherapies work in each patient.


Back to home Page top